Overview

A Second Study to Determine the Effect of GSK256073A on HVTs

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects that have been administrated GSK256073 in the HMA107787 study
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline